In vitro susceptibility of Malassezia furfur to antifungal compounds from HIV-positive and negative patients
Trabajo de grado Microbiologia
- Autores:
-
Contreras Carreño, Andrés Guillermo
- Tipo de recurso:
- Trabajo de grado de pregrado
- Fecha de publicación:
- 2021
- Institución:
- Universidad de los Andes
- Repositorio:
- Séneca: repositorio Uniandes
- Idioma:
- eng
- OAI Identifier:
- oai:repositorio.uniandes.edu.co:1992/56961
- Acceso en línea:
- http://hdl.handle.net/1992/56961
- Palabra clave:
- Malassezia furfur
Antifungal
HIV
Susceptibility
Malassezia furfur
Infecciones por VIH
Salud pública
Enfermos de sida
Personas VIH positivas
VIH
Sida
Microbiología
- Rights
- openAccess
- License
- Attribution-NonCommercial-NoDerivatives 4.0 Internacional
id |
UNIANDES2_a2dbf0dcd70a3bffa5cd6e3244833cb8 |
---|---|
oai_identifier_str |
oai:repositorio.uniandes.edu.co:1992/56961 |
network_acronym_str |
UNIANDES2 |
network_name_str |
Séneca: repositorio Uniandes |
repository_id_str |
|
dc.title.none.fl_str_mv |
In vitro susceptibility of Malassezia furfur to antifungal compounds from HIV-positive and negative patients |
title |
In vitro susceptibility of Malassezia furfur to antifungal compounds from HIV-positive and negative patients |
spellingShingle |
In vitro susceptibility of Malassezia furfur to antifungal compounds from HIV-positive and negative patients Malassezia furfur Antifungal HIV Susceptibility Malassezia furfur Infecciones por VIH Salud pública Enfermos de sida Personas VIH positivas VIH Sida Microbiología |
title_short |
In vitro susceptibility of Malassezia furfur to antifungal compounds from HIV-positive and negative patients |
title_full |
In vitro susceptibility of Malassezia furfur to antifungal compounds from HIV-positive and negative patients |
title_fullStr |
In vitro susceptibility of Malassezia furfur to antifungal compounds from HIV-positive and negative patients |
title_full_unstemmed |
In vitro susceptibility of Malassezia furfur to antifungal compounds from HIV-positive and negative patients |
title_sort |
In vitro susceptibility of Malassezia furfur to antifungal compounds from HIV-positive and negative patients |
dc.creator.fl_str_mv |
Contreras Carreño, Andrés Guillermo |
dc.contributor.advisor.none.fl_str_mv |
Ehemann Guerrero, Kevin Celis Ramírez, Adriana Marcela |
dc.contributor.author.none.fl_str_mv |
Contreras Carreño, Andrés Guillermo |
dc.contributor.researchgroup.es_CO.fl_str_mv |
Grupo de Investigación Celular y Molecular de Microorganismos Patógenos (CeMoP) |
dc.subject.keyword.none.fl_str_mv |
Malassezia furfur Antifungal HIV Susceptibility |
topic |
Malassezia furfur Antifungal HIV Susceptibility Malassezia furfur Infecciones por VIH Salud pública Enfermos de sida Personas VIH positivas VIH Sida Microbiología |
dc.subject.armarc.none.fl_str_mv |
Malassezia furfur Infecciones por VIH Salud pública Enfermos de sida Personas VIH positivas VIH Sida |
dc.subject.themes.es_CO.fl_str_mv |
Microbiología |
description |
Trabajo de grado Microbiologia |
publishDate |
2021 |
dc.date.issued.none.fl_str_mv |
2021-12-14 |
dc.date.accessioned.none.fl_str_mv |
2022-04-25T14:41:01Z |
dc.date.available.none.fl_str_mv |
2022-04-25T14:41:01Z |
dc.type.es_CO.fl_str_mv |
Trabajo de grado - Pregrado |
dc.type.driver.none.fl_str_mv |
info:eu-repo/semantics/bachelorThesis |
dc.type.version.none.fl_str_mv |
info:eu-repo/semantics/acceptedVersion |
dc.type.coar.none.fl_str_mv |
http://purl.org/coar/resource_type/c_7a1f |
dc.type.content.es_CO.fl_str_mv |
Text |
dc.type.redcol.none.fl_str_mv |
http://purl.org/redcol/resource_type/TP |
format |
http://purl.org/coar/resource_type/c_7a1f |
status_str |
acceptedVersion |
dc.identifier.uri.none.fl_str_mv |
http://hdl.handle.net/1992/56961 |
dc.identifier.instname.es_CO.fl_str_mv |
instname:Universidad de los Andes |
dc.identifier.reponame.es_CO.fl_str_mv |
reponame:Repositorio Institucional Séneca |
dc.identifier.repourl.es_CO.fl_str_mv |
repourl:https://repositorio.uniandes.edu.co/ |
url |
http://hdl.handle.net/1992/56961 |
identifier_str_mv |
instname:Universidad de los Andes reponame:Repositorio Institucional Séneca repourl:https://repositorio.uniandes.edu.co/ |
dc.language.iso.es_CO.fl_str_mv |
eng |
language |
eng |
dc.relation.references.es_CO.fl_str_mv |
Gaitanis G, Magiatis P, Hantschke M, Bassukas ID, Velegraki A. The Malassezia genus in skin and systemic diseases. Clinical microbiology reviews. 2012 Jan;25(1):106-41. Velegraki A, Cafarchia C, Gaitanis G, Iatta R, Boekhout T. Malassezia infections in humans and animals: pathophysiology, detection, and treatment. PLoS pathogens. 2015 Jan 8;11(1):e1004523. Lorch JM, Palmer JM, Vanderwolf KJ, Schmidt KZ, Verant ML, Weller TJ, et al. Malassezia vespertilionis sp. Nov.: A new cold-tolerant species of yeast isolated from bats. Persoonia: Molecular Phylogeny Evol Fungi. 2018;41:56-70. Jo JH, Deming C, Kennedy EA, Conlan S, Polley EC, Ng W lan, et al. Diverse Human Skin Fungal Communities in Children Converge in Adulthood. Journal of Investigative Dermatology. 2016 Dec 1;136(12):2356-63. Rhimi W, Theelen B, Boekhout T, Otranto D, Cafarchia C. Malassezia spp. Yeasts of Emerging Concern in Fungemia. Frontiers in Cellular and Infection Microbiology. 2020;10 Saunte DML, Gaitanis G, Hay RJ. Malassezia-Associated Skin Diseases, the Use of Diagnostics and Treatment. Frontiers in Cellular and Infection Microbiology. 2020 Mar 20; 10:112 Wang K, Cheng L, Li W, Jiang H, Zhang X, Liu S, Huang Y, Qiang M, Dong T, Li Y, Wang J. Susceptibilities of Malassezia strains from pityriasis versicolor, Malassezia folliculitis and seborrheic dermatitis to antifungal drugs. Heliyon. 2020 Jun 1;6(6):e04203. Dessinioti C, Katsambas A. Seborrheic dermatitis: etiology, risk factors, and treatments: facts and controversies. Clinics in dermatology. 2013 Jul 1;31(4):343-51. Ehemann K, Sastoque A, Guevara-Suarez M, Celis AM. Evaluación de inhibidores candidatos del crecimiento de las especies del género Malassezia. 2019;(September). Available from: t: https://www.researchgate.net/publication/336055637 Galvis-Marín JC, Rodríguez-Bocanegra MX, del Pilar Pulido-Villamarín A, Castañeda-Salazar R, Celis-Ramírez AM, Linares-Linares MY. Actividad antifúngica in vitro de azoles y anfotericina B frente a Malassezia furfur por el método de microdilución M27-A3 del CLSI y Etest. Revista Iberoamericana de Micología. 2017 Apr 1;34(2):89-93. Galvis Marín JC, Borda Rojas F. Infecciones zoonéticas causadas por levaduras del género Malassezia: una revisión. Revista UDCA Actualidad & Divulgación Científica. 2016 Dec;19(2):381-93. Huang CY, Peng CC, Hsu CH, Chang JH, Chiu NC, Chi H. Systemic Infection Caused by Malassezia pachydermatis in Infants: Case Series and Review of the Literature. The Pediatric infectious disease journal. 2020 May 1;39(5):444- 8. Chen IT, Chen CC, Huang HC, Kuo KC. Malassezia furfur emergence and candidemia trends in a neonatal intensive care unit during 10 years: the experience of fluconazole prophylaxis in a single hospital. Advances in Neonatal Care. 2020 Feb;20(1):E3. Pedrosa AF, Lisboa C, Rodrígues AG. Malassezia infections with systemic involvement: Figures and facts. The Journal of Dermatology. 2018 Nov;45(11):1278-82. Moreno-couti G, Sánchez-cárdenas CD, Arroyo-Escalante S, Arenas R. Isolation of Malassezia spp. in HIV-positive patients with and without seborrheic dermatitis. Anais Brasileiros de Dermatología. 2019 Dec;94:527- 31. Krzysciak P, Bakula Z, Gniadek A, Garlicki A, Tarnowski M, Wichowski M, et al. Prevalence of Malassezia species on the skin of HIV-seropositive patients. Scientific Reports. 2020 Oct 20;10(1):1-13. Amado Y, Patiño-Uzcátegui A, Cepero De García MC, Tabima J, Motta A, Cárdenas M, et al. Seborrheic dermatitis: Predisposing factors and ITS2 secondary structure for Malassezia phylogenic analysis. Medical Mycolgy. 2013 Nov 1;51(8):868-75. Cafarchia C, Figueredo LA, Iatta R, Colao V, Montagna MT, Otranto D. In vitro evaluation of Malassezia pachydermatis susceptibility to azole compounds using E-test and CLSI microdilution methods. Medical Mycology. 2012 Nov;87(8):795-801. Álvarez-Pérez S, Blanco JL, Peláez T, Cutuli M, García ME. In vitro amphotericin B susceptibility of Malassezia pachydermatis determined by the CLSI broth microdilution method and etest using lipid-enriched media. Antimicrobial Agents and Chemotherapy. 2014 Jul;58(7):4203-6. Rhimi W, Aneke CI, Mosca A, Otranto D, Cafarchia C. In vitro azole and amphotericin B susceptibilities of Malassezia furfur from bloodstream infections using e-test and CLSI broth microdilution methods. Antibiotics. 2020 Jun;9(6):361 Rojas FD, De Los A. Sosa M, Fern¿ndez MS, Cattana ME, Córdoba SB, Giusiano GE. Antifungal susceptibility of Malassezia furfur, Malassezia sympodialis, and Malassezia globosa to azole drugs and amphotericin B evaluated using a broth microdilution method. Medical Mycology. 2014 Jun 25;52(6):641-6. Pedrosa AF, Carmen L, Faria-Ramos I, Silva R, Ricardo E, Teixeira-Santos R, et al. Epidemiology and susceptibility profile to classic antifungals and overthe- counter products of Malassezia clinical isolates from a Portuguese University Hospital: A prospective study. Journal of Medical Microbiology. 2019 May;68(5):778-84. Cafarchia C, Iatta R, Immediato D, Puttilli MR, Otranto D. Azole susceptibility of Malassezia pachydermatis and Malassezia furfur and tentative epidemiological cut-off values. Med Mycology. 2015 Sep 1;53(7):743-8. Iatta R, Figueredo LA, Montagna MT, Otranto D, Cafarchia C. In vitro antifungal susceptibility of Malassezia furfur from bloodstream infections. Journal of Medical Microbiology. 2014 Nov 1;63:1467-73. Clinical ALSI. Document M27-A4. Ref Method Broth Dilution Antifung Suscetibility Test Yeasts. 2012; Patel JB, Sharp S, Novak-Weekley S. Verification of Antimicrobial Susceptibility Testing Methods: A Practical Approach. Clinical Microbiology Newsletter. 2013 Jul 1;35(13):103-9. Iatta R, Immediato D, Montagna MT, Otranto D, Cafarchia C. In vitro activity of two amphotericin B formulations against Malassezia furfur strains recovered from patients with bloodstream infections. Medical Mycology. 2015 Apr 1;53(3):269-74 Ford N, Meintjes G, Calmy A, Bygrave H, Migone C, Vitoria M, Penazzato M, Vojnov L, Doherty M. Managing advanced HIV disease in a public health approach. Clinical Infectious Diseases. 2018 Mar 4;66:106-110. Velegraki A, Alexopoulos EC, Kritikou S, Gaitanis G. Use of fatty acid RPMI 1640 media for testing susceptibilities of eight Malassezia species to the new triazole posaconazole and to six established antifungal agents by a modified NCCLS M27-A2 microdilution method and Etest. Journal of Clinical Microbiology. 2004 Aug;42(8):3589-93. Rojas FD, Córdoba SB, de los Ángeles Sosa M, Zalazar LC, Fernández MS, Cattana ME, et al. Antifungal susceptibility testing of Malassezia yeast: comparison of two different methodologies. Mycoses. 2017 Feb;60(2):104-11. Ramesh N, Priyadharsini M, Sumathi CS, Balasubramanian V, Hemapriya J, Kannan R. Virulence Factors and Anti Fungal Sensitivity Pattern of Candida Sp. Isolated from HIV and TB Patients. Indian Journal of Microbiology. 2011 Jul;51(3):273-8. Law D, Moore CB, Wardle HM, Ganguli LA, Keaney MGL, Denning DW. High prevalence of antifungal resistance in Candida spp. From patients with AIDS. Journal of Antimicrobial Chemotherapy. 1994 Nov 1;34(5):659-68. Osaigbovo II, Lofor P V., Oladele RO. Fluconazole resistance among oral Candida isolates from people living with HIV/AIDS in a Nigerian tertiary hospital. Journal of Fungi. 2017 Dec;3(4):69. |
dc.rights.license.spa.fl_str_mv |
Attribution-NonCommercial-NoDerivatives 4.0 Internacional |
dc.rights.uri.*.fl_str_mv |
http://creativecommons.org/licenses/by-sa/4.0/ |
dc.rights.accessrights.spa.fl_str_mv |
info:eu-repo/semantics/openAccess |
dc.rights.coar.spa.fl_str_mv |
http://purl.org/coar/access_right/c_abf2 |
rights_invalid_str_mv |
Attribution-NonCommercial-NoDerivatives 4.0 Internacional http://creativecommons.org/licenses/by-sa/4.0/ http://purl.org/coar/access_right/c_abf2 |
eu_rights_str_mv |
openAccess |
dc.format.extent.none.fl_str_mv |
14 páginas |
dc.publisher.es_CO.fl_str_mv |
Universidad de los Andes |
dc.publisher.program.es_CO.fl_str_mv |
Microbiología |
dc.publisher.faculty.es_CO.fl_str_mv |
Facultad de Ciencias |
dc.publisher.department.es_CO.fl_str_mv |
Departamento de Ciencias Biológicas |
institution |
Universidad de los Andes |
bitstream.url.fl_str_mv |
https://repositorio.uniandes.edu.co/bitstreams/42738c56-a1dd-470d-b164-ecfb1d28aae0/download https://repositorio.uniandes.edu.co/bitstreams/3a0c4aec-7952-4ee9-9367-5a5fc497b065/download https://repositorio.uniandes.edu.co/bitstreams/694e1ec5-baae-4bf9-a007-9d982bb594fe/download https://repositorio.uniandes.edu.co/bitstreams/24a08438-754a-4e4a-9c66-aff665b06252/download https://repositorio.uniandes.edu.co/bitstreams/6c0468c1-f1d9-4a2d-9613-d28ede0e8348/download https://repositorio.uniandes.edu.co/bitstreams/f43af684-82bd-48a1-898f-ca1e1c3382c7/download https://repositorio.uniandes.edu.co/bitstreams/a07b0f2d-35e9-48a0-82d6-1e2bf38c9e40/download https://repositorio.uniandes.edu.co/bitstreams/d99ea8ec-c82a-4b90-a3d8-21ed7004c566/download |
bitstream.checksum.fl_str_mv |
8c1ac0ca86e9951cda2cc3a2047c8221 e400e592cffaea73516cc55d2f729a9a 77c7ac7b170a442a767359c710fcf95c 68b329da9893e34099c7d8ad5cb9c940 5aa5c691a1ffe97abd12c2966efcb8d6 84a900c9dd4b2a10095a94649e1ce116 cf9c51d894fff94984fb5090705e492b 29fa91d2846c815c84a971e1222823d4 |
bitstream.checksumAlgorithm.fl_str_mv |
MD5 MD5 MD5 MD5 MD5 MD5 MD5 MD5 |
repository.name.fl_str_mv |
Repositorio institucional Séneca |
repository.mail.fl_str_mv |
adminrepositorio@uniandes.edu.co |
_version_ |
1812133943457087488 |
spelling |
Attribution-NonCommercial-NoDerivatives 4.0 Internacionalhttp://creativecommons.org/licenses/by-sa/4.0/info:eu-repo/semantics/openAccesshttp://purl.org/coar/access_right/c_abf2Ehemann Guerrero, Kevin11807ce0-23bd-453a-bfe3-1a6b7b7a4bc5600Celis Ramírez, Adriana Marcelavirtual::9151-1Contreras Carreño, Andrés Guillermo579e5171-6eb7-4fed-9177-52b9929274ee600Grupo de Investigación Celular y Molecular de Microorganismos Patógenos (CeMoP)2022-04-25T14:41:01Z2022-04-25T14:41:01Z2021-12-14http://hdl.handle.net/1992/56961instname:Universidad de los Andesreponame:Repositorio Institucional Sénecarepourl:https://repositorio.uniandes.edu.co/Trabajo de grado MicrobiologiaMalassezia is a genus of lipophilic and lipid-dependent yeast. Despite being part of skin microbiota, it can produce local and systemic opportunistic infections. Azole and amphotericin B antifungals are the main treatment to eradicate the disease. Given the difficulty for in vitro growth, no susceptibility tests are standardized; therefore, little is known about antifungal susceptibility patterns. Although Human Immunodeficiency Virus (HIV) seropositive patients have a higher concentration of Malassezia yeasts in the skin, no difference in antifungal resistance patterns has been sought compared to the seronegative population. Therefore, we compared susceptibility patterns in 20 isolates of Malassezia furfur in HIV-positive and negative populations, comparing the Epsilon Test technique with the reference method Broth Microdilution Test. Isolates showed a high Minimum Inhibitory Concentration to amphotericin B, while itraconazole is the antifungal, to which all isolates are most sensitive. As for HIV status, only itraconazole showed a statistical difference between seropositive and negative. None of the antifungals proved to be compared using the techniques in the study; hence more studies need to be performed.MicrobiólogoPregrado14 páginasengUniversidad de los AndesMicrobiologíaFacultad de CienciasDepartamento de Ciencias BiológicasIn vitro susceptibility of Malassezia furfur to antifungal compounds from HIV-positive and negative patientsTrabajo de grado - Pregradoinfo:eu-repo/semantics/bachelorThesisinfo:eu-repo/semantics/acceptedVersionhttp://purl.org/coar/resource_type/c_7a1fTexthttp://purl.org/redcol/resource_type/TPMalassezia furfurAntifungalHIVSusceptibilityMalassezia furfurInfecciones por VIHSalud públicaEnfermos de sidaPersonas VIH positivasVIHSidaMicrobiologíaGaitanis G, Magiatis P, Hantschke M, Bassukas ID, Velegraki A. The Malassezia genus in skin and systemic diseases. Clinical microbiology reviews. 2012 Jan;25(1):106-41.Velegraki A, Cafarchia C, Gaitanis G, Iatta R, Boekhout T. Malassezia infections in humans and animals: pathophysiology, detection, and treatment. PLoS pathogens. 2015 Jan 8;11(1):e1004523.Lorch JM, Palmer JM, Vanderwolf KJ, Schmidt KZ, Verant ML, Weller TJ, et al. Malassezia vespertilionis sp. Nov.: A new cold-tolerant species of yeast isolated from bats. Persoonia: Molecular Phylogeny Evol Fungi. 2018;41:56-70.Jo JH, Deming C, Kennedy EA, Conlan S, Polley EC, Ng W lan, et al. Diverse Human Skin Fungal Communities in Children Converge in Adulthood. Journal of Investigative Dermatology. 2016 Dec 1;136(12):2356-63.Rhimi W, Theelen B, Boekhout T, Otranto D, Cafarchia C. Malassezia spp. Yeasts of Emerging Concern in Fungemia. Frontiers in Cellular and Infection Microbiology. 2020;10Saunte DML, Gaitanis G, Hay RJ. Malassezia-Associated Skin Diseases, the Use of Diagnostics and Treatment. Frontiers in Cellular and Infection Microbiology. 2020 Mar 20; 10:112Wang K, Cheng L, Li W, Jiang H, Zhang X, Liu S, Huang Y, Qiang M, Dong T, Li Y, Wang J. Susceptibilities of Malassezia strains from pityriasis versicolor, Malassezia folliculitis and seborrheic dermatitis to antifungal drugs. Heliyon. 2020 Jun 1;6(6):e04203.Dessinioti C, Katsambas A. Seborrheic dermatitis: etiology, risk factors, and treatments: facts and controversies. Clinics in dermatology. 2013 Jul 1;31(4):343-51.Ehemann K, Sastoque A, Guevara-Suarez M, Celis AM. Evaluación de inhibidores candidatos del crecimiento de las especies del género Malassezia. 2019;(September). Available from: t: https://www.researchgate.net/publication/336055637Galvis-Marín JC, Rodríguez-Bocanegra MX, del Pilar Pulido-Villamarín A, Castañeda-Salazar R, Celis-Ramírez AM, Linares-Linares MY. Actividad antifúngica in vitro de azoles y anfotericina B frente a Malassezia furfur por el método de microdilución M27-A3 del CLSI y Etest. Revista Iberoamericana de Micología. 2017 Apr 1;34(2):89-93.Galvis Marín JC, Borda Rojas F. Infecciones zoonéticas causadas por levaduras del género Malassezia: una revisión. Revista UDCA Actualidad & Divulgación Científica. 2016 Dec;19(2):381-93.Huang CY, Peng CC, Hsu CH, Chang JH, Chiu NC, Chi H. Systemic Infection Caused by Malassezia pachydermatis in Infants: Case Series and Review of the Literature. The Pediatric infectious disease journal. 2020 May 1;39(5):444- 8.Chen IT, Chen CC, Huang HC, Kuo KC. Malassezia furfur emergence and candidemia trends in a neonatal intensive care unit during 10 years: the experience of fluconazole prophylaxis in a single hospital. Advances in Neonatal Care. 2020 Feb;20(1):E3.Pedrosa AF, Lisboa C, Rodrígues AG. Malassezia infections with systemic involvement: Figures and facts. The Journal of Dermatology. 2018 Nov;45(11):1278-82.Moreno-couti G, Sánchez-cárdenas CD, Arroyo-Escalante S, Arenas R. Isolation of Malassezia spp. in HIV-positive patients with and without seborrheic dermatitis. Anais Brasileiros de Dermatología. 2019 Dec;94:527- 31.Krzysciak P, Bakula Z, Gniadek A, Garlicki A, Tarnowski M, Wichowski M, et al. Prevalence of Malassezia species on the skin of HIV-seropositive patients. Scientific Reports. 2020 Oct 20;10(1):1-13.Amado Y, Patiño-Uzcátegui A, Cepero De García MC, Tabima J, Motta A, Cárdenas M, et al. Seborrheic dermatitis: Predisposing factors and ITS2 secondary structure for Malassezia phylogenic analysis. Medical Mycolgy. 2013 Nov 1;51(8):868-75.Cafarchia C, Figueredo LA, Iatta R, Colao V, Montagna MT, Otranto D. In vitro evaluation of Malassezia pachydermatis susceptibility to azole compounds using E-test and CLSI microdilution methods. Medical Mycology. 2012 Nov;87(8):795-801.Álvarez-Pérez S, Blanco JL, Peláez T, Cutuli M, García ME. In vitro amphotericin B susceptibility of Malassezia pachydermatis determined by the CLSI broth microdilution method and etest using lipid-enriched media. Antimicrobial Agents and Chemotherapy. 2014 Jul;58(7):4203-6.Rhimi W, Aneke CI, Mosca A, Otranto D, Cafarchia C. In vitro azole and amphotericin B susceptibilities of Malassezia furfur from bloodstream infections using e-test and CLSI broth microdilution methods. Antibiotics. 2020 Jun;9(6):361Rojas FD, De Los A. Sosa M, Fern¿ndez MS, Cattana ME, Córdoba SB, Giusiano GE. Antifungal susceptibility of Malassezia furfur, Malassezia sympodialis, and Malassezia globosa to azole drugs and amphotericin B evaluated using a broth microdilution method. Medical Mycology. 2014 Jun 25;52(6):641-6.Pedrosa AF, Carmen L, Faria-Ramos I, Silva R, Ricardo E, Teixeira-Santos R, et al. Epidemiology and susceptibility profile to classic antifungals and overthe- counter products of Malassezia clinical isolates from a Portuguese University Hospital: A prospective study. Journal of Medical Microbiology. 2019 May;68(5):778-84.Cafarchia C, Iatta R, Immediato D, Puttilli MR, Otranto D. Azole susceptibility of Malassezia pachydermatis and Malassezia furfur and tentative epidemiological cut-off values. Med Mycology. 2015 Sep 1;53(7):743-8.Iatta R, Figueredo LA, Montagna MT, Otranto D, Cafarchia C. In vitro antifungal susceptibility of Malassezia furfur from bloodstream infections. Journal of Medical Microbiology. 2014 Nov 1;63:1467-73.Clinical ALSI. Document M27-A4. Ref Method Broth Dilution Antifung Suscetibility Test Yeasts. 2012;Patel JB, Sharp S, Novak-Weekley S. Verification of Antimicrobial Susceptibility Testing Methods: A Practical Approach. Clinical Microbiology Newsletter. 2013 Jul 1;35(13):103-9.Iatta R, Immediato D, Montagna MT, Otranto D, Cafarchia C. In vitro activity of two amphotericin B formulations against Malassezia furfur strains recovered from patients with bloodstream infections. Medical Mycology. 2015 Apr 1;53(3):269-74Ford N, Meintjes G, Calmy A, Bygrave H, Migone C, Vitoria M, Penazzato M, Vojnov L, Doherty M. Managing advanced HIV disease in a public health approach. Clinical Infectious Diseases. 2018 Mar 4;66:106-110.Velegraki A, Alexopoulos EC, Kritikou S, Gaitanis G. Use of fatty acid RPMI 1640 media for testing susceptibilities of eight Malassezia species to the new triazole posaconazole and to six established antifungal agents by a modified NCCLS M27-A2 microdilution method and Etest. Journal of Clinical Microbiology. 2004 Aug;42(8):3589-93.Rojas FD, Córdoba SB, de los Ángeles Sosa M, Zalazar LC, Fernández MS, Cattana ME, et al. Antifungal susceptibility testing of Malassezia yeast: comparison of two different methodologies. Mycoses. 2017 Feb;60(2):104-11.Ramesh N, Priyadharsini M, Sumathi CS, Balasubramanian V, Hemapriya J, Kannan R. Virulence Factors and Anti Fungal Sensitivity Pattern of Candida Sp. Isolated from HIV and TB Patients. Indian Journal of Microbiology. 2011 Jul;51(3):273-8.Law D, Moore CB, Wardle HM, Ganguli LA, Keaney MGL, Denning DW. High prevalence of antifungal resistance in Candida spp. From patients with AIDS. Journal of Antimicrobial Chemotherapy. 1994 Nov 1;34(5):659-68.Osaigbovo II, Lofor P V., Oladele RO. Fluconazole resistance among oral Candida isolates from people living with HIV/AIDS in a Nigerian tertiary hospital. Journal of Fungi. 2017 Dec;3(4):69.201213193Publication0000-0003-3057-1966virtual::9151-1https://scienti.minciencias.gov.co/cvlac/visualizador/generarCurriculoCv.do?cod_rh=0000178225virtual::9151-17ec7a7b4-b510-4816-b236-023aaa0754f0virtual::9151-17ec7a7b4-b510-4816-b236-023aaa0754f0virtual::9151-1THUMBNAILTesis Final (1).pdf.jpgTesis Final (1).pdf.jpgIM Thumbnailimage/jpeg25543https://repositorio.uniandes.edu.co/bitstreams/42738c56-a1dd-470d-b164-ecfb1d28aae0/download8c1ac0ca86e9951cda2cc3a2047c8221MD58Formato Autorizacion.pdf.jpgFormato Autorizacion.pdf.jpgIM Thumbnailimage/jpeg14864https://repositorio.uniandes.edu.co/bitstreams/3a0c4aec-7952-4ee9-9367-5a5fc497b065/downloade400e592cffaea73516cc55d2f729a9aMD510TEXTTesis Final (1).pdf.txtTesis Final (1).pdf.txtExtracted texttext/plain32747https://repositorio.uniandes.edu.co/bitstreams/694e1ec5-baae-4bf9-a007-9d982bb594fe/download77c7ac7b170a442a767359c710fcf95cMD57Formato Autorizacion.pdf.txtFormato Autorizacion.pdf.txtExtracted texttext/plain1https://repositorio.uniandes.edu.co/bitstreams/24a08438-754a-4e4a-9c66-aff665b06252/download68b329da9893e34099c7d8ad5cb9c940MD59LICENSElicense.txtlicense.txttext/plain; charset=utf-81810https://repositorio.uniandes.edu.co/bitstreams/6c0468c1-f1d9-4a2d-9613-d28ede0e8348/download5aa5c691a1ffe97abd12c2966efcb8d6MD51CC-LICENSElicense_rdflicense_rdfapplication/rdf+xml; charset=utf-81025https://repositorio.uniandes.edu.co/bitstreams/f43af684-82bd-48a1-898f-ca1e1c3382c7/download84a900c9dd4b2a10095a94649e1ce116MD54ORIGINALTesis Final (1).pdfTesis Final (1).pdfTrabajo de Gradoapplication/pdf1059225https://repositorio.uniandes.edu.co/bitstreams/a07b0f2d-35e9-48a0-82d6-1e2bf38c9e40/downloadcf9c51d894fff94984fb5090705e492bMD55Formato Autorizacion.pdfFormato Autorizacion.pdfHIDEapplication/pdf111039https://repositorio.uniandes.edu.co/bitstreams/d99ea8ec-c82a-4b90-a3d8-21ed7004c566/download29fa91d2846c815c84a971e1222823d4MD561992/56961oai:repositorio.uniandes.edu.co:1992/569612024-03-13 13:51:40.522http://creativecommons.org/licenses/by-sa/4.0/open.accesshttps://repositorio.uniandes.edu.coRepositorio institucional Sénecaadminrepositorio@uniandes.edu.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 |